登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《SSRN，2月19日，The Risk of Death in 2019 Novel Coronavirus Disease (COVID-19) in Hubei Province》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-20

  • The Risk of Death in 2019 Novel Coronavirus Disease (COVID-19) in Hubei Province

    40 Pages Posted: 19 Feb 2020

    Vincent Yi Fong Su

    Taipei Veterans General Hospital - Department of Chest Medicine

    Yao-Hsu Yang

    Chang Gung Memorial Hospital - Health Information and Epidemiology Laboratory

    Abstract

    Background: The current outbreak of novel coronavirus (2019-nCoV or SARS-CoV-2) in China and globally requires urgent research to guide the appropriate treatment of patients with coronavirus disease 2019 (COVID-19).

    Methods: We conducted a case-control study to the evaluate risk factors of death in patients with COVID-19. We used published data of cases from Huanan Seafood Market, Jinyintan Hospital, and deaths publicly released by the Government. The study included 41 patients partially exposed to the Huanan Seafood Market, 99 patients from Jinyintan Hospital, and 32 deaths (COVID-19 death group).

  • 原文来源：https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3539655
155浏览量
原文链接
相关报告

  • 《MedRxiv，3月6日，Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-07
    • Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province Hui Wan, Jing-an Cui, Guo-Jing Yang doi: https://doi.org/10.1101/2020.03.01.20029629 Abstract Background: In December 2019, an outbreak of novel coronavirus disease (COVID-19) emerged in Wuhan, China and has swiftly spread to other parts of China and a number of oversea countries. Our aim is to evaluate the effectiveness of the evolution of interventions and self-protection measures, estimate the risk of partial lifting control measures and predict the epidemic trend of the virus in mainland China excluding Hubei province based on the published data and a novel mathematical model. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    106浏览量
    原文链接

  • 《JAMA，3月31日，Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-06
    • Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China Ping Wu, MD1; Fang Duan, MD2; Chunhua Luo, MD1; et al Qiang Liu, MD1; Xingguang Qu, MD1; Liang Liang, MD1; Kaili Wu, MD2 Author Affiliations Article Information JAMA Ophthalmol. Published online March 31, 2020. doi:10.1001/jamaophthalmol.2020.1291 Abstract Importance While the outbreak of coronavirus disease 2019 (COVID-19) has resulted in more than 100?000 infected individuals in China and worldwide, there are few reports on the association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with ocular abnormalities. Understanding ocular manifestations of patients with COVID-19 by ophthalmologists and others may facilitate the diagnosis and prevention of transmission of the disease. Objective To investigate ocular manifestations and viral prevalence in the conjunctiva of patients with COVID-19.
    42浏览量
    原文链接